Home  »  Company  »  BDH Industries Ltd.  »  Quotes  »  Company History
Enter the first few characters of Company and click 'Go'

BDH Industries Ltd. Company History and Annual Growth Details

BDH Industries Ltd. was incorporated on 5th December, 1990 as a Private Limited Company. The Company was converted into Public Limited Company vide special resolution passed
in the Extra Ordinary General Meeting of the Company held on 1st April, 1994. & obtained a fresh Certificate of Change of Name upon conversion was received on 29th April, 1994.

BDH Industries Limited was incorporated with main object of taking over a going concern, M/s. Bombay Drug House Pvt. Ltd. for facilitating growth plans in time with the emerging scenario and to fulfill the objective of Quality Growth for Globalisation".

Bombay Drug House Pvt. Ltd. an existing profit making & dividend paying Company was amalgamated with this Company pursuant to the order of Hon'ble High Court of Bombay dated
4th March, 1994. Bombay Drug House Pvt. Ltd. was incorporated on 13th December, 1943 and has built a good reputation locally and internationally for its products which are mainly formulations and bulk drugs. The Company has been a regular exporter and has received several prestigious awards like Top Export Award, Coveted TRISHUL Award, etc.

Bombay Drug House Pvt. Ltd. over the years has been a front runner in Exports of Formulations. The Company's products are registered in many developing countries. For the last 15 years the company has received kudos from Ministry of Commerce, Chemexcil, and Govt. of Maharashtra. 15 awards have been bestowed on the Company. The Company has a well
established international clientele & global business associates.

The Company has entered into a MOU with NEPOTHENE GROUP PVT. LTD.,("Nepothene") Nepal for providing it assistance in setting up a pharmaceutical company, namely NPOTHENE-BDH PHARMA PVT. LTD. registered in Nepal. As per the terms of the MOU, the Company shall provide Brand Name, Technical and Marketing support to Nepothene. The consideration payable by Nepothene is 5% of the Project Cost for providing the services.

The Company is presently engaged in the manufacturing of a wide range of formulations like antifungal, antibiotics, anti-cancer, anti-bacterial, Analgesic, Antiinflammatory, anti-TB, Cardio-Vascular, anti-histamines, Vitamins etc. The Company now proposes to modernise and expand its production facilities. The Company also proposes to manufacture Parental and herbal based formulations.

SUBSIDIARY COMPANY

The Company does not have any subsidiary company.

2008

-BDH Industries has designated E-mail ID for Investors Complaints: [email protected]

2011

-BDH Industries have recommended dividend @ 5%

2012

-BDH Industries have recommended dividend @ 6%

2013
- BDH Industries Ltd has recommended dividend @10%.

2014
- BDH Industries Ltd has recommended dividend @ 12%.
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X